Press Releases
Pharmaceutical Packaging And Manufacturing Trends To Be Covered By...
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2021) will cover the topics of cutting-edge technologies and digitalization in the Manufacturing and Packaging processes of the pharmaceutical...
Clinical Trials
Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875
Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) announced that the first cancer patients have started treatment with its investigational antibody-drug conjugate (ADC) SYD1875.
The First-in-Human Dose-Escalation and...
Press Releases
LANXESS disinfectant kills coronavirus SARS-CoV-2 in just 60 seconds
Rely+On Virkon broad spectrum disinfectant, produced by specialty Chemicals Company LANXESS, demonstrates extremely rapid efficacy against the SARS-CoV-2 virus.
This is the finding of a recent...
Drug Research
Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology...
Gilead Sciences, Inc. and Tango Therapeutics announced an expanded strategic collaboration focused on the discovery, development and commercialization of innovative targeted immune evasion therapies for...
Press Releases
Europe’s Largest Initiative Launches to Accelerate Therapy Development for...
CARE (Corona Accelerated R&D in Europe) a new consortium supported by the Innovative Medicines Initiative (IMI) public-private partnership announced its launched to accelerate the discovery...
Press Releases
OSE Immunotherapeutics Publishes Positive Preclinical COVID-19 Vaccine Results With...
OSE Immunotherapeutics announced the online publication in BioRxiv of positive data from preclinical and human ex vivo studies with CoVepiT, its prophylactic vaccine program based...
Press Releases
AstraZeneca concludes agreement with the European Commission for the...
AstraZeneca has concluded an agreement with the European Commission (EC) to supply up to 400 million doses of the AZD1222 COVID-19 vaccine. Building on the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.